TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
FLGT

Fulgent Genetics Inc

Healthcare · Diagnostics & Research

22.20$ +3.0% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

Fulgent Genetics Inc (FLGT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -102 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow FLGT
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-4.4 -1.0 4.4 1.3 -0.7 5.5 141 539 254 27 21 -102
0.2 0.6 1.2 1.7 2.2 2.5 3.0 11 33 26 25 24
– 8.2 4.7 2.1 2.3 3.2 8.2 16 33 43 44 40
0.0 8.5 10 2.8 3.7 4.2 8.7 23 75 – – –
-0.3 -1.7 -1.9 -0.7 -1.2 -0.9 -91 -2.7 2.0 2.8 -7.2 -118
0.7 2.1 3.8 5.4 2.8 1.2 37 24 19 22 40 23
-0.8 -2.2 -43 -2.0 1.0 -29 -326 -547 -261 39 -58 111
4.6 4.6 4.6 0.0 – – 15 4.2 – – – –
37 37 -6.6 0.0 0.0 0.0 -0.1 -4.2 -76 -28 -3.1 -14
– – – 15 15 15 15 0.0 -1.1 -20 -1.8 -0.9
4.0 3.5 46 -0.8 0.0 29 261 85 -77 -48 -4.8 -15
-1.2 0.3 7.4 -1.4 0.2 5.2 75 77 -85 18 -42 -5.0
-5.1 -3.1 0.6 -4.0 -3.5 4.3 104 515 235 4.8 -19 -124

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?